Epilepsy is a serious neurological condition that can affect individuals of all ages. Treatment is far from perfect, and roughly 30% of patients can experien…
Cannabinoid Clinical Trials: CBD & Cortical Excitability
Clinical Takeaway In this controlled trial of healthy adults, neither a low nor a high single dose of CBD directly altered cortical excitability compared to placebo, suggesting CBD may not have meaningful...
`Cannabidiol & Cortical Excitability: Clinical Trial Findings`
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial in healthy adults, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability compared to placebo. This...
Cannabinoids in Children: Medical Evidence Reviewed
Clinical Takeaway Cannabinoids have been studied across a wide range of pediatric medical conditions, with evidence drawn from interventional trials, observational data, and surveys. The current body of research reflects both potential...
`Cannabidiol & Cortical Excitability: Clinical Trial Evidence`
Clinical Takeaway In a controlled crossover trial of healthy males, CBD at both low and high single doses failed to directly reduce cortical excitability compared to placebo, suggesting its anti-seizure effects may...
Endocannabinoid System Research: CBD & Cortical Excitability
Clinical Takeaway In a controlled crossover trial in healthy adults, CBD at both low and high doses showed no direct effect on cortical excitability compared to placebo, suggesting its anti-seizure benefit may...